Calciphylaxis in Pre‑dialysis Chronic Kidney Disease: Case Report
DOI:
https://doi.org/10.71749/pkj.64Keywords:
Calciphylaxis/etiology, Calciphylaxis/therapy, Renal Dialysis, Renal Insufficiency, Chronic/complicationsAbstract
Calciphylaxis is a rare life‑threatening vasculopathy resulting from calcium deposition in the arteriolar microvasculature of the deep dermis and subcutaneous adipose tissue, mainly occurring in end‑stage kidney disease (ESKD) treated with maintenance dialysis. Calciphylaxis in patients without ESKD is even rarer, which makes the diagnosis of calciphylaxis challenging in this population. In patients with any stage of kidney disease, there should be high clinical suspicion of calciphylaxis after the appearance of painful nodules, indurated plaques, dusky livedoid plaques, or nonblanching retiform purpura. We present a clinical case of a 75‑year‑old female with stable stage 5 chronic kidney disease who developed an ulcerated skin lesion on the posterior surface of the right lower limb, in whom calciphylaxis was not initially suspected because several common risk factors were not present, such as maintenance dialysis, altered calcium‑phosphate product or warfarin use. A biopsy‑proven diagnosis of calciphylaxis was made. Re‑epithelialization of the ulcerated lesions was achieved after the induction of haemodialysis, administering sodium thiosulfate in each dialysis session, wound care, and pain control through a multidisciplinary approach. Early identification and directed therapy initiation may be lifesaving in a disease that portends an ominous prognosis.Downloads
References
Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018;378(18):1704-1714. doi:10.1056/ NEJMra1505292
Weenig RH, Sewell LD, Davis MDP, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56(4):569-579. doi: 10.1016/j.jaad.2006.08.065
Saifan C, Saad M, El-Charabaty E, El-Sayegh S. Warfarin-induced calciphylaxis: A case report and review of literature. Int J Gen Med 2013; 6: 665-9. doi:10.2147/IJGM.S47397
Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008 Jul;3(4):1139-43. doi: 10.2215/CJN.00530108. Epub 2008 Apr 16. PMID: 18417747; PMCID: PMC2440281
O’Keeffe C, Barbosa E, O’Kane M. Biopsy-proven calciphylaxis in the Irish National Kidney Transplant Center 2010-2019. Int J Dermatol. 2021;60(7):901-903. doi:10.1111/ijd.15516
McCarthy JT, El-Azhary RA, Patzelt MT, et al. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc. 2016;91(10):1384-1394. doi:10.1016/j. mayocp.2016.06.025
Gabel CK, Nguyen ED, Chakrala T, et al. Assessment of outcomes of calciphylaxis. J Am Acad Dermatol. 2021;85(4): 1057-1064. doi:10.1016/j.jaad.2020.10.067
Gallo Marin B, Aghagoli G, Hu SL, Massoud CM, Robinson-Bostom L. Calciphylaxis and Kidney Disease: A Review. Am J Kidney Dis. 2023 Feb;81(2):232-239. doi: 10.1053/j.ajkd.2022.06.011. Epub 2022 Aug 12. PMID: 35970430
Georgesen C, Fox LP, Harp J. Retiform purpura: a diagnostic approach. J Am Acad Dermatol. 2020;82(4):783-796. doi:10. 1016/j.jaad.2019.07.112
Gabel CK, Blum AE, François J, et al. Clinical mimickers of calciphylaxis: a retrospective study. J Am Acad Dermatol. 2021;85(6):1520-1527. doi:10.1016/j.jaad.2021.03.035
Yousuf S, Busch D, Renner R, Schliep S, Erfurt-Berge C. Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience. Ren Fail. 2024 Dec;46(1):2297566. doi: 10.1080/0886022X.2023.2297566. Epub 2024 Jan 4. PMID: 38178572; PMCID: PMC10773653
Nigwekar SU, Zhao S, Wenger J, et al. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol. 2016;27(11):3421-3429. doi:10.1681/ASN.2015091065
Zhang L, Zhao Y, Guo Z, Ma J, Ma Y, Yang Z. Does serum calcium level play a practical role in calciphylaxis in hemodialysis patients? Ren Fail. 2021;43(1):1506-1507. doi:10.1080/0886022X.2021.1999828
Brandenburg VM, Kramann R, Rothe H, et al. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nation- wide registry. Nephrol Dial Transplant 2017;32:126-32. Doi: 10.1093/ndt/gfv438
Kalajian AH, Malhotra PS, Callen JP, Parker LP. Calciphylaxis with normal renal and parathyroid function: not as rare as previously believed. Arch Dermatol. 2009;145(4):451-458. doi:10.1001/archdermatol.2008.602
Bahrani E, Perkins IU, North JP. Diagnosing calciphylaxis: a review with emphasis on histopathology. Am J Dermatopathol. 2020;42(7):471-480. doi:10.1097/DAD.0000000000001526
Mochel MC, Arakaki RY, Wang G, Kroshinsky D, Hoang MP. Cutaneous calciphylaxis: a retrospective histopathologic evaluation. Am J Dermatopathol. 2013;35(5):582-586. doi:10.1097/DAD.0b013e31827c7f5d
O’Connor HM, Wu Q, Lauzon SD, Forcucci JA. Diffuse dermal angiomatosis associated with calciphylaxis: A 5-year retrospective institutional review. J Cutan Pathol. 2020;47(1):27- 30. doi:10.1111/cup.13585
An J, Devaney B, Ooi KY, Ford S, Frawley G, Menahem S. Hyperbaric oxygen in the treatment of calciphylaxis: A case series and literature review. Nephrology (Carlton). 2015 Jul;20(7):444-50. doi: 10.1111/nep.12433. PMID: 25707425
Kusari A, Cotter D, Hinds B, Paravar T. Non-uremic calciphylaxis in a patient with multiple rheumatologic diseases. Dermatol Online J. 2019 Feb 15;25(2):13030/qt2fg525bs. PMID: 30865406
Downloads
Published
Data Availability Statement
This case was presented at Encontro Renal 2022 as a poster with the title “Calcifilaxia Urémica num Doente Renal Crónico em Fase Pré-dialítica”. This research data is not presently available on any platform.
Issue
Section
License
Copyright (c) 2025 André Ferreira, Rebeca Calado, José Carlos Cardoso, Ana Galvão, Rui Alves

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.